Siegfried Holding AG
SIX:SFZN
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
746.5
1 182
|
Price Target |
|
We'll email you a reminder when the closing price reaches CHF.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one SFZN stock under the Base Case scenario is 1 193.15 CHF. Compared to the current market price of 1 120 CHF, Siegfried Holding AG is Undervalued by 6%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Siegfried Holding AG
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for SFZN cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Siegfried Holding AG
Balance Sheet Decomposition
Siegfried Holding AG
Current Assets | 964.3m |
Cash & Short-Term Investments | 64.9m |
Receivables | 361.5m |
Other Current Assets | 537.9m |
Non-Current Assets | 913.5m |
Long-Term Investments | 597k |
PP&E | 833.7m |
Intangibles | 45.9m |
Other Non-Current Assets | 33.3m |
Current Liabilities | 357.6m |
Accounts Payable | 91.1m |
Accrued Liabilities | 102.3m |
Other Current Liabilities | 164.2m |
Non-Current Liabilities | 613.4m |
Long-Term Debt | 430m |
Other Non-Current Liabilities | 183.4m |
Earnings Waterfall
Siegfried Holding AG
Revenue
|
1.3B
CHF
|
Cost of Revenue
|
-952.1m
CHF
|
Gross Profit
|
332.2m
CHF
|
Operating Expenses
|
-154.3m
CHF
|
Operating Income
|
177.9m
CHF
|
Other Expenses
|
-49.7m
CHF
|
Net Income
|
128.2m
CHF
|
Free Cash Flow Analysis
Siegfried Holding AG
CHF | |
Free Cash Flow | CHF |
SFZN Profitability Score
Profitability Due Diligence
Siegfried Holding AG's profitability score is 55/100. The higher the profitability score, the more profitable the company is.
Score
Siegfried Holding AG's profitability score is 55/100. The higher the profitability score, the more profitable the company is.
SFZN Solvency Score
Solvency Due Diligence
Siegfried Holding AG's solvency score is 73/100. The higher the solvency score, the more solvent the company is.
Score
Siegfried Holding AG's solvency score is 73/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
SFZN Price Targets Summary
Siegfried Holding AG
According to Wall Street analysts, the average 1-year price target for SFZN is 1 204.28 CHF with a low forecast of 999.9 CHF and a high forecast of 1 575 CHF.
Dividends
Current shareholder yield for SFZN is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
SFZN Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Siegfried Holding AG engages in the development and manufacture of active pharmaceutical ingredients for pharmaceutical clients with research and development programs, related intermediates, and controlled substances. The company is headquartered in Zofingen, Aargau and currently employs 3,432 full-time employees. The firm produces both drug substances and drug products. The drug substance portfolio includes contract development and manufacturing of both active pharmaceutical ingredients (APIs) and intermediates. The drug products portfolio comprises licensing and contract or co-development and manufacturing of oral solids and steriles. The firm's products and substances are developed for treatment of hypertension, benign prostate hyperplasia, depression, chronic myeloid leukemia, glaucoma, asthma, schizophrenia and bipolar disorders and diabetes. The firm operates production facilities in Switzerland, Germany, France, Malta, the United States and China.
Contact
IPO
Employees
Officers
The intrinsic value of one SFZN stock under the Base Case scenario is 1 193.15 CHF.
Compared to the current market price of 1 120 CHF, Siegfried Holding AG is Undervalued by 6%.